Abstract
Measurement of the Doubling Times [DT] for 27 human pulmonary neoplasms have been made. Squamous and large cell tumours had a wide range of values for DT whereas for small cell undifferentiated carcinoma, and possibly large cell undifferentiated carcinomata without stratification, the range was narrower. Mean DT for different primary bronchogenic carcinoma groups were: Squamous cell 146 days, Adenocarcinoma 72 days, Small cell 66 days, and Large Cell 111 days. The number of adenocarcinomata is very small in number and our value of 72 days is probably not representative of this group of tumours. Relationship between DT and tumour differentiation was difficult to identify in our series. Of these 27 a unique series of 17 have parallel data on DT and Potential Doubling Time (DTpot) and the Cell Loss Factor [0] calculated. Great discrepancy between DT and DTpot existed in each case and cell loss was high, ranging from 54% to 99%. All primary bronchogenic carcinomata had cell loss of greater than 70%; in almost two thirds of these cases the value was 90% or more. All undifferentiated tumours and a majority of poorly differentiated tumours had cell loss of 90% or more. As cell loss increased, tumour thymidine labelling index (TLI) increased and the tumours tended to be less well differentiated. The relationship, if any, between cell loss and DT was unclear.
Highlights
Great discrepancy between Doubling Time (DT) and DTpot existed in each case and cell loss was high, ranging from 54% to 99%
All primary bronchogenic carcinomata had cell loss of >70%; in almost two thirds of these cases the value was 90% or more
In this paper we present a series of twenty seven human pulmonary neoplasms for which DT has been determined
Summary
Relationship between DT and tumour differentiation was difficult to identify in our series Of these 27 a unique series of 17 have parallel data on DT and Potential Doubling Time (DTpot) and the Cell Loss Factor [0] calculated. The method devised by Steel for determining DTpot from the TLI of a tumour cell population takes account of growth fraction. Cell loss factor for human tumours has, due to lack of parallel data, been estimated using results pooled from various sources in the literature (Terz et al, 1971; Malaise et al, 1973; see Steel, 1977). In this paper we present a series of twenty seven human pulmonary neoplasms for which DT has been determined In seventeen of these cases parallel data on DT and DTpot have been obtained and cell loss factors deduced
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.